TTUHSC Welcome to the HSC
HomeWelcome

Profile




Profile for Lingkun Kong, MD, PhD

Lingkun Kong

Lingkun Kong, MD, PhD

  • Associate Professor Ophthalmology Dept Lubbock Genl
Mail Address: 3601 4th St Stop 7217
Lubbock TX 79430-7217

Post Doctoral Education:

  • Pediatric Ophthalmology Fellowship: Southwestern University Medical School, 2010
  • Resident: Texas Tech University Health Sciences Center, 2009
  • Ocular Pathology Fellowship: The Methodist Hospital, 2008
  • Postdoctoral Research Fellow: Baylor College of Medicine, 2007
  • Graduate Student: The Prince Charles Hospital, 2003

Education:

  • PhD: University of Queensland, 2003
  • MD: Harbin Medical University, 1988

Selected Publications:

  • Cao, Jennifer & Wagner, Brandie & Cerda, Ashlee & McCourt, Emily & Palestine, Alan & Enzenauer, Robert & Braverman, Rebecca & Wong, Ryan & Tsui, Irena & Gore, Charlotte & Robbins, Shira & Puente, Michael & Kauffman, Levi & Kong, Lingkun & Morrison, David & Lynch, Anne June (2016) Colorado retinopathy of prematurity model: a multi-institutional validation study. J AAPOS, 20, 3, 220-5.
  • Kong, Lingkun & Demny, Ann & Sajjad, Ahmar & Bhatt, Amit & Devaraj, Sridevi April (2016) Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants. Invest. Ophthalmol. Vis. Sci., 57, 4, 1649-54.
  • Shah, Ravi & Weikert, Mitchell & Grannis, Charity & Hamill, Marshall & Kong, Lingkun & Yen, Kimberly January (2016) Long-Term Outcomes of Iris-fixed Posterior Chamber Intraocular Lenses in Children. Am. J. Ophthalmol., 161, 44-9.e1.
  • Kong, Lingkun & Dinh, K & Schechet, S & Coats, D & Voigt, R & Steinkuller, P (2015) Comparison of ocular and developmental outcomes in laser-and bevacizumab-treated infants with retinopathy of prematurity. Ophthalmology Research: an International Journal, 3, 1, 13-22.
  • Pediatric Eye Disease Investigator Group, February (2015) A randomized trial of levodopa as treatment for residual amblyopia in older children. Ophthalmology.

Selected Presentations:

  • Serum biomarker for ROP. Dubai, United Arab Emirates; November 2016.
  • Pathogenesis for Periventricular leukomalacia and ROP. Osaka, Japan; May 2016.
  • The Role of Hyperoxia-Induced Vasoconstriction of Cerebral Blood Vessels and Glycolysis in the Development of ROP and PVL. The Association for Research in Vision and Ophthalmology (ARVO), Seattle, Washington; May 2016.
  • Colorado ROP Screening Model: A Multi-Institutional Validation Study. American Association for Pediatric Ophthalmology and Strabismus (AAPOS), New Orleans, Louisiana; 2015.
  • Long Term Developmental Improvement in Children with Neurobehavioral Disorders Following Photorefractive Keratectomy for Bilateral Isoametropic Amblyopia. American Association for Pediatric Ophthalmology and Strabismus (AAPOS), New Orleans, Louisiana; 2015.

Selected Contracts and Grants:

  • A randomized trial of bilateral lateral rectus recession versus unilateral lateral rectus recession with medial rectus resection for intermittent exotropia (IXT1) 2012-2017
    Awarded by National Eye Institute (NEI)
    Other

  • Amblyopia treatment study : increasing patching for amblyopia (AST15) 2012-2017
    Awarded by National Eye Institute (NEI)
    Other

  • Amblyopia treatment study : Levodopa as treatment for residual amblyopia (AST17) 2012-2017
    Awarded by National Eye Institute (NEI)
    Other

  • Amblyopia treatment study : long-term follow up (AST1) 2012-2017
    Awarded by National Eye Institute (NEI)
    Other

  • Effectiveness of home-based therapy for symptomatic convergence insufficiency (CITS) 2012-2017
    Awarded by National Eye Institute (NEI)
    Other

Selected Non-Credit Instruction Taught:

  • Pharmacokinetics and serum cytokines in bevacizumab treated infants - 2016
  • The Role of Hyperoxia-Induced Vasoconstriction of Cerebral Blood Vessels and Glycolysis in the Development of ROP and PVL - 2016
  • Management for Retinopathy of Prematurity - 2015
  • Current Trend on Pediatric Eye Disease Research - 2014
  • Update of Pediatric Ophthalmology Research - 2012
Date last updated: 1/16/2018
Research Interests

Dr. Kong's main research interests are gene regulation of retinal development and retinopathy of prematurity.

Clinical Interests

Dr. Kong is fellowship trained pediatric ophthalmologist. Her main clinical focus are pediatric ophthalmology, adult strabismus and ROP.

©